Credential Qtrade Securities Inc. Takeda Pharmaceutical CO LTD Transaction History

Credential Qtrade Securities Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jul 21, 2025	SELL	$13.17 - $16.4 $602,659 - $750,463	-45,760 Closed	0 $0
Q3 2021 Jul 21, 2025	BUY	$16.3 - $17.26 $106,928 - $113,225	6,560 Added 16.73%	45,760 $750 Million
Q2 2021 Jul 21, 2025	BUY	$16.55 - $18.64 $192,311 - $216,596	11,620 Added 42.13%	39,200 $660 Million
Q1 2021 Jul 21, 2025	BUY	$16.71 - $19.9 $460,861 - $548,842	27,580 New	27,580 $504 Million
Q2 2020 Jul 21, 2025	SELL	$14.59 - $19.5 $875 - $1,170	-60 Closed	0 $0
Q2 2019 Jul 21, 2025	SELL	$16.58 - $20.49 $3,332 - $4,118	-201 Reduced 77.01%	60 $1.06 Million
Q1 2019 Jul 21, 2025	BUY	$16.7 - $21.52 $4,358 - $5,616	261 New	261 $5.32 Million

379

73.2M

1.68M

157K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Credential Qtrade Securities Inc., based on Form 13F filings with the SEC.

Stay updated on Credential Qtrade Securities Inc. with notifications on news.